LOGIN
Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo
September 2018
Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study
Clin Gastroenterol Hepatol. 2017 Jul;15(7):1079-1086.e4. doi: 10.1016/j.cgh.2016.09.147Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
65 patients with chronic abdominal pain following surgery or due to chronic pancreatitis were randomized to receive delta-9-tetrahydrocannabinol (THC) or placebo for 50-52 days. The primary outcome was pain relief, as measured by a visual analogue scale (VAS). Secondary outcomes included other measures of pain, depression, anxiety, quality of life, treatment satisfaction, appetite, alertness, mood...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.